Found 7 matching trials
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. PHASE1 The objective of this study is to assess the overall response rate, evaluat...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) PHASE1 This is a Phase 1b/2 dose-optimization study to evaluate safety, pharmacoki...
Show More Location
UCSD Medical Center - Encinitas
Learn More & Join Trial
Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis PHASE2 The purpose of this study is to determine the safety and tolerability of ad...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma PHASE1 This is an open label, two-phase study combining a dose escalation Phase 1 ...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer PHASE1 This clinical trial will examine a novel combination of anti-OX40 to induce...
Show More Location
Providence Portland Medical Center
Learn More & Join Trial
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer PHASE1 This study is designed to determine the safety and highest tolerated dose o...
Show More Location
Providence Cancer Center
Learn More & Join Trial
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors PHASE1 The purpose of this study is to assess the safety and tolerability of BGB-A...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial